Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
WHSC1
REST API REST API
Homo sapiens
WHSC1 is differentially expressed in 371 experiments: 168 organism parts: bone marrow, testis, ... (166 more);, 264 disease states: normal, prostate carcinoma, ... (262 more);, 136 cell types 521 cell lines 58 compound treatments and 85 other conditions.
Synonyms NSD2, MMSET
Orthologs E1C765_CHICK (Gallus gallus)   WHSC1 (Bos taurus)   Whsc1 (Rattus norvegicus)   Whsc1 (Mus musculus)   whsc1 (Danio rerio)   whsc1 (Xenopus laevis)   WHSC1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term DNA binding, protein binding, regulation of transcription, DNA-dependent, cytoplasm, metal ion binding, methyltransferase activity, anatomical structure morphogenesis, nucleus, chromatin binding, transferase activity, chromosome, chromatin modification, negative regulation of transcription from RNA polymerase II promoter, nucleolus, histone-lysine N-methyltransferase activity, nuclear membrane, zinc ion binding, membranous septum morphogenesis, atrial septum primum morphogenesis, bone development, histone lysine methylation, atrial septum secundum morphogenesis, peptidyl-lysine methylation
InterPro Term Znf_PHD-finger, AWS, Znf_RING, Znf_PHD, Post-SET_dom, HMG_HMG1/HMG2, PWWP, SET_dom
UniProt Accession D6R9V2, O96028, D6RIS1, D6RFE7, Q05CW4, A2A2T2
Gene-Disease Assocation WOLF-HIRSCHHORN SYNDROME; WHS
Search EB-eye ENSG00000109685
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-GEOD-1577, E-MEXP-433, ... (36 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, ... (45 experiments)

Factor Value U/D Experiments
SW480
3
E-MTAB-37, E-GEOD-18005, E-MEXP-1014
A549
2
E-GEOD-3202, E-GEOD-6013
HL-60
2
E-GEOD-24147, E-MTAB-37
HT1080
2
E-MTAB-37, E-GEOD-20089
MOLT4
2
E-MTAB-37, E-MTAB-62
PC3
2
E-MEXP-2034, E-GEOD-14464
515 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, ... (59 experiments)

Factor Value U/D Experiments
CD14+ monocyte
3
E-MEXP-1600, E-AFMX-5, E-TABM-145
human foreskin fibroblast
2
E-GEOD-18265, E-GEOD-18147
partially reprogrammed human induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
CD34+
2
E-AFMX-5, E-TABM-145
1
2
E-TABM-145, E-TABM-130
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
130 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-GEOD-1577, ... (82 experiments)

Factor Value U/D Experiments
prostate carcinoma
1
4
E-GEOD-96, E-MEXP-2034, E-MTAB-62, E-MTAB-37, E-MEXP-1327 ... (5 experiments)
colon carcinoma
3
E-MTAB-62, E-MTAB-37, E-GEOD-3726
glioblastoma
3
E-GEOD-4290, E-GEOD-6014, E-MTAB-37
lung adenocarcinoma
3
E-MTAB-37, E-MEXP-231, E-MTAB-62
septic shock
2
E-GEOD-8121, E-GEOD-9692
myeloma
2
E-MTAB-372, E-MTAB-62
258 more value(s).


Compound treatment

studied in E-GEOD-4668, E-GEOD-5741, E-TABM-782, E-GEOD-3720, E-GEOD-5824, ... (35 experiments)

Factor Value U/D Experiments
dimethyl sulfoxide
2
E-GEOD-5824, E-GEOD-6932
lipopolysaccharide
2
E-MEXP-1958, E-GEOD-3720
HMB-PP (phosphoantigen)
1
E-MEXP-1601
control for EGF
1
E-GEOD-6462
TNF
1
E-GEOD-15205
untreated
1
E-GEOD-15389
52 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
29
2
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, ... (11 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-MEXP-1251, E-GEOD-2191, ... (11 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, E-GEOD-4667, ... (8 experiments)

Dfs evt
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-TABM-26, E-MTAB-69, E-GEOD-22148, ... (9 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-6919, E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-GEOD-4025, E-MEXP-1482, E-GEOD-7578, ... (10 experiments)

Genotype
studied in E-GEOD-1045, E-TABM-1029, E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, ... (17 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, E-GEOD-22278, E-GEOD-10315, ... (16 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-302, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-2069, E-GEOD-1926, E-TABM-26, ... (38 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-980, ... (7 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-TABM-321, E-MEXP-2177

Karyotype
studied in E-GEOD-7214, E-GEOD-22056

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-7819, E-GEOD-26495, E-GEOD-19703, E-GEOD-22152, E-GEOD-21750, ... (11 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (7 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-GEOD-1676, E-GEOD-3697, E-MEXP-1857, E-MEXP-1315, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276, E-GEOD-2748

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, ... (8 experiments)

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 00 005
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561, E-GEOD-4922, E-TABM-147

Vehicle
studied in E-GEOD-5258

Processing time: 0.488 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM